$SU.PA

Schneider Electric Plans €1.2 Billion Bid for Bulgarian Shelly Group

Schneider Electric (SU.PA) plans to acquire Bulgarian smart-building company Shelly Group for €1.2 billion. The offer of €70 per share represents a 22% premium. Shelly's founders, owning 57% of shares, support the deal, pending regulatory approval and Schneider acquiring 95% of Shelly's capital. Completion is expected in Q1 2027.

Original reporting
Published Sep 24, 2026, 1:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 1:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Schneider Electric Plans €1.2 Billion Bid for Bulgarian Shelly Group — source image
Decision brief

The 30-second read

$SU.PABullishHigh
01

Why it matters

The €1.2 bn offer represents a strategic move into the connected‑device market, potentially enhancing Schneider's product ecosystem and market share in Europe.

02

Market read

First‑report of a sizable European M&A deal; may influence sector sentiment and provide a trading catalyst for Schneider.

03

What to watch

Financing method and integration risk for Schneider's existing portfolio are not detailed.

Relevance 9/10Novelty 9/10Timing: today

Background

Schneider Electric, a French energy‑tech leader, seeks to expand its smart‑building portfolio through the acquisition of Shelly Group.

Company-level read

Ticker impact

$SU.PABullishHigh confidence
Context

Schneider Electric announced a €1.2 bn cash bid to acquire Shelly Group, a fresh M&A offer.

Expected impact

Potential modest upside for SU.PA if the deal clears regulatory approval.

Evidence & confidence

Large‑scale acquisition at a 22‑27% premium is material; market typically rewards acquirers with strategic growth prospects.

Market effects

Smart‑building and IoT sector may see consolidation, boosting peers with similar technology portfolios.

Bulgarian market could experience increased foreign investment interest.

Highlights European industrial players' push into connected‑device space, relevant for global tech investors.

Counterpoint

Deal could face regulatory hurdles in Bulgaria, risking a collapse and a short‑term sell‑off in Schneider.

Key entities

  • Schneider Electric

    Acquirer, listed on Euronext Paris (SU).

  • Shelly Group

    Bulgarian smart‑building and connected‑device firm, privately held.

Related articles

$SU.PAHighAI 9/10

Schneider Electric shells out $22 billion for PTC's industrial AI software

Schneider Electric agreed to acquire PTC, a maker of industrial design software, for $22.6 billion. The French conglomerate aims to expand its software portfolio to better serve factories, data centers, and electric utilities. Software and services accounted for 18% of Schneider's Q2 revenue. According to Schneider's CEO, the deal is driven by the growing role of industrial AI in physical products and systems.

AI stocks slide after major CEOs unite to urge slowdown

AI-related stocks fell globally after Anthropic CEO Dario Amodei called for a slowdown in AI development, supported by other tech leaders. Companies like SK Hynix, Samsung, SoftBank, ASML, Nokia, Infineon, Micron, Intel, Nvidia, Microsoft, Amazon, and Alphabet saw declines. Investors fear a slowdown could impact sector growth and adoption, potentially affecting future earnings.

$PAGHighAI 9/10

UBS raises Penske Automotive stock price target on merger deal

UBS raised its price target for Penske Automotive Group (PAG) to $212, matching the $212 per share offer from Penske Corp. and Mitsui & Co. to take the company private. The offer represents a 14.9x multiple on UBS's 2027 EPS estimate. PAG reported strong Q2 2026 earnings, exceeding expectations with $3.62 EPS and $8.5B revenue, a 6% YoY increase. Stephens also raised its price target to $210, citing strong financial performance.

$OPKHighAI 8/10

Piper Sandler raises Opko Health stock price target on LabCorp deal

Piper Sandler raised its price target for Opko Health (OPK) to $4.00 from $3.00, citing the sale of its BioReference lab business to LabCorp for up to $872 million. OPK stock is up 17% in the past week. The company reported Q2 2026 revenue of $163.6 million, beating estimates, and a smaller-than-expected loss of $0.01 per share. OPK has $314.4 million in cash and $349 million in debt, with a current ratio of 3.35.